Drugs / Lyophilized fecal microbiome transfer
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05709184 | Nov 2023 → Nov 2025 | Clostridium infectious disease | Rambam Health Care Campus | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lyophilized fecal microbiome transfer | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05709184 ↗ |
| Known as | Lyo-FMT | “Lyophilized fecal microbiome transfer (Lyo-FMT)” NCT05709184 ↗ |
| Modality | Other / unclassified | “a dried extract of bacteria from the stool of healthy donors” NCT05709184 ↗ |
| Route | Oral | “oral lyophilized FMT capsules” NCT05709184 ↗ |